PREVAIL Act

Intellectual property issues including patent, copyright, and trademark issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1097 - Interagency Patent Coordination and Improvement Act of 2025. H.R.3160/S.1553 - PREVAIL Act. H.R.1574/S.708 - RESTORE Patent Rights Act of 2025. S.2276 - A bill to address patent thickets. S.2658 - Medication Affordability and Patent Integrity Act (MAPIA). H.R.3269/S.2276 - Eliminating Thickets to Increase Competition Act (ETHIC Act). USPTO Fee-Setting Authority.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1367/H.R.2794, NO FAKES Act of 2025, NO FAKES Act of 2026 / S. 4591 H.R. 10025, Preventing Abuse of Digital Replicas Act Proposals for blocking foreign piracy websites, including H.R. 10364, American Copyright Protection Act of 2026, and S. 5529/H.R. 10575, DEFEND IP Act of 2026 S. 1546/H.R. 3152, Patent Eligibility Restoration Act of 2025 S. 1553/H.R. 3160, Promoting and Respecting Economically Vital American Innovation Leadership Act S. 708/H.R. 1574, RESTORE Patent Rights Act of 2025 H.R. 7140, Customer Legal Ease and Relief (CLEAR) Act

Client expense: $1,424,847 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Patent quality issues and preserving the Patent Trial and Appeal Board (PTAB) - S. 1553, HR 3160, the PREVAIL Act; S. 1546, HR 3152, the Patent Eligibility Restoration Act of 2023. Customer stay legislation - HR 7140 - Customer Legal Ease and Relief Act or the CLEAR" Act. USPTO NPRM to change the rules of practice for Inter Partes Review (IPR) before the Patent Trial Advisory Board (PTAB).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

Patent Protection and IP issues generally. S. 1546, Patent Eligibility and Restoration Act (PERA) HR 3152, Patent Eligibility and Restoration Act (PERA) S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) HR 3160, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL)

Client expense: $750,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

Patent quality issues and preserving the Patent Trial and Appeal Board (PTAB). S. 1553, HR 3160, the PREVAIL Act; S. 1546, HR 3152, the Patent Eligibility Restoration Act of 2023

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

Issues related to intellectual property, including the NO FAKES Act (S. 1367), counterfeits, music licensing, and issues related to patent reform, International Trade Commission patent investigations, intermediary liability, and patent reform, including the RESTORE Patents Act (H.R. 1574 / S. 708), the Patent Eligibility Restoration (PERA) Act (H.R. 3152 / S. 1546), and the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R. 3160 / S. 1553).

Client expense: $4,490,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues

Client expense: $7,040,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues

Client expense: $1,530,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025 Issues related to Patent Trial and Appeal Board procedures

Client expense: $1,610,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. H.R. 9681, Fair Seeds for Farmers Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act. S. 5104, Fair Seeds for Farmers Act.

Client expense: $1,710,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025

Client expense: $3,150,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Coalition for Intellectual Property. Intellectual property and innovation policy oversight. Patent Reform Legislation. H.R.3160/S.1553: PREVAIL Act. 101 Reform and similar legislation.

Client expense: Not reported · Firm income: $50,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE

Issues related to the rules governing the Patent Trial and Appeals Board, including both legislative and regulatory proposals. PREVAIL Act, S. 1553 Patent Eligibility Restoration Act, S. 1546. General opposition to legislative efforts to weaken the Patent Trial & Appeal Board at the USPTO.

Client expense: Not reported · Firm income: $20,000

Government targets: SENATE

Issues related to patent reform legislation. Issues related to H.R. 3160/S. 1553 - The PREVAIL Act.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to intellectual property legislation and regulation; H.R. 3152/S. 1546, Patent Eligibility Restoration Act of 2025; H.R. 3160/S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act); H.R. 1574/S. 708, RESTORE Patent Rights Act of 2025; USPTO Rulemaking related to Inter Partes Review; H.R. 9142, Prohibiting Adversarial Patents Act; H.R. 1109, Litigation Transparency Act of 2025; S. 3826, Litigation Funding Transparency Act of 2026; H.R. 2675, Protecting Our Courts from Foreign Manipulation Act; H.R. 7015, Protecting TPLF From Abuse Act

Client expense: Not reported · Firm income: $70,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, White House Office

Intellectual property and patent issues; Standard Essential Patents; Intellectual Property/Patent enforcement at the International Trade Commission; H.R. 3152/S. 1546, Patent Eligibility Restoration Act of 2025; H.R. 3160/S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act); H.R. 1574/S. 708, RESTORE Patent Rights Act of 2025; USPTO Rulemaking related to Inter Partes Review; Export Control issues

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

Software copyright and related policy issues. Software patents and related policy issues. S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S. 1546, Patent Eligibility Restoration Act. S. 1367, NO FAKES Act. S. 4098, AI Ready Data Act.

Client expense: $2,440,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Copyright Office, U.S. Trade Representative (USTR)

Met with Senators, Representatives, and legislative staff to discuss university intellectual property and technology transfer operations, and to encourage support for the PREVAIL (HR 3160, S.1553), PERA (HR 3512, S.1546), and RESTORE (HR 1578, S.704) Acts. Met with Senators, Representatives, and legislative staff to encourage support for efforts to prevent agencies from indiscriminately exercising march-in rights to invalidate university patents or licenses, or to discourage the administration from claiming a portion of patent royalties.

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to patent rights and patent enforcement; Issues related to H.R. 3160/S. 1553 - PREVAIL Act; Issues related to H.R. 3152/S. 1546 - Patent Eligibility Restoration Act of 2025; Issues related to H.R. 1574/S. 708 - RESTORE Patent Rights Act of 2025; Issues related to Section 337; H.R. 8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027; Issues related to the NPRM on Revision to Rules of Practice Before the Patent Trial and Appeal Board.

Client expense: Not reported · Firm income: $80,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

S. 4784 / H.R. 8800 National Defense Authorization Act H.R. 7015: Protecting Third Party Litigation Funding From Abuse Act S. 3826: Litigation Funding Transparency Act of 2026 35 U.S.C. 5: Patent Public Advisory Committee (PPAC) and the Trademark Public Advisory Committee (TPAC) 35 U.S.C. 10: USPTO Fee-Setting Authority  S. 1553 / H.R. 3160 PREVAIL Act

Client expense: $50,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

S.3971- SBIR/STTR Reauthorization Act of 2026 H.R. 5100 - To extend the SBIR and STTR programs, and for other purposes S.1546 - Patent Eligibility Restoration Act of 2025 S.1553 - PREVAIL Act H.R.5223 - RESTORE Act of 2025 -- regarding policy issues affecting higher education institutions and their faculty and students

Client expense: $125,337 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Patent legislation generally; Intellectual property/antitrust issues; RESTORE Patent Rights Act of 2025 (H.R. 1574, S. 708); PREVAIL Act (S. 1553, H.R. 3160); Patent Eligibility Restoration Act (S. 1546, H.R. 3152); Leadership in CET Act (S. 1833, H.R. 3539).

Client expense: Not reported · Firm income: $610,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE

H.R. 5811: Restoring Americas Leadership in Innovation Act of 2025; All provisions of the bill; H.R. 5819: Balancing Incentives Act of 2025; All provisions of the bill; S. 708 / HR. 1574 RESTORE Patent Rights Act of 2025: All provisions of the bill; S. 1546 / HR. 3152 Patent Eligibility Restoration Act of 2025: All provisions of the bill; S. 1553 / HR. 3160 PREVAIL Act: All provisions of the bill.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3160/S.1553: Promoting and Respecting Economically Viable American Innovation (PREVAIL) Act.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 708 and H.R. 1534 -- RESTORE Patent Rights Act of 2025 -- issues related to injunctions for patent infringement S. 1546 and H.R. 3152 -- Patent Eligibility Restoration Act -- related to clarifications of Section 101 of patent law S. 1553 and H.R. 3160 -- PREVAIL Act (Promoting and Respecting Economically Vital American Innovation Leadership Act -- related to reforms of the Patent Trials and Appeals Board at the US Patent and Trademark Office Teleconference with OIRA and USPTO re: Revision to Rules of Practice before the Patent Trial and Appeals Board Extension of PTO's fee-sharing authority which expired in September 2026 Restrictions in federal research grants that could lead to payments to government

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, White House Office

S.1546 Patent Eligibility Restoration Act of 2025; S.1553 PREVAIL Act; S.708 RESTORE Patent Rights Act of 2025. USPTO Proposed Rulemakings on PTAB Reform and Disclosure of Real Parties in Interest.

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE

H.R. 10575/S. 5529, the Deterring Extraterritorial Foreign Exploitation of Networks Damaging Intellectual Property (DEFEND IP) Act of 2026 S. 5104/H.R. 9681, Fair Seeds for Farmers Act H.R. 10204, Legislative Branch Agencies Clarification Act H.R 10364 American Copyright Protection Act of 2026 H.R. 10026, Honoring Circuit Judge Pauline Newman Act of 2026 H.R. 10025, Preventing Abuse of Digital Replicas Act H.R. 7140, Customer Legal Ease and Relief Act (CLEAR Act) H.R. 5811, Restoring Americas Leadership in Innovation Act of 2025 S. 3517, the Visual Artists Copyright Reform Act of 2025 H.R. 6517, To modify the appointment process for the Librarian of Congress, the Comptroller General, and the Director of the Government Publishing Office, and for other purposes H.R. 6028, Legislative Branch Agencies Clarification Act S. 1546/H.R. 3152, Patent Eligibility Restoration Act (PERA) of 2025 S. 1553/ H.R. 3160, Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) S. 1833/H.R. 3539, Leadership in CET Act S. 2677/H.R. 4930, To expand the sharing of information with respect to suspected violations of intellectual property rights in trade S. 2455, TRAIN Act S. 2276/H.R. 3269, ETHIC Act H.R. 1566, the Right to Equitable and Professional Auto Industry Repair (REPAIR) Act H.R. 890, A bill to amend title 35, United States Code, to prevent double patenting, and for other purposes. H.R.1109, the Litigation Transparency Act of 2025 H.R. 2675, Protecting Our Courts from Foreign Manipulation Act of 2025 S. 1367/H.R. 5794, NO FAKES H.R 791, Foreign Anti-Digital Piracy Act (FADPA) S. 1097, Interagency Patent Coordination and Improvement Act of 2025 S. 1096, Preserve Access to Affordable Generics and Biosimilars Act S. 1041, Affordable Prescriptions for Patients Act S. 708/H.R. 1574, RESTORE Patent Rights Act of 2025 H.R. 6485/S. 43, Skinny Labels, Big Savings Act Issues related to USPTO operations Issues related to international patent harmonization Issues related to patent subject matter eligibility Issues related to Copyright Office Operations

Client expense: $10,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Library of Congress (LOC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR), White House Office

H.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. H.R.3152/S.1546: Patent Eligibility Restoration Act of 2025. H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act. S.2658: Medication Affordability and Patent Integrity Act. S.1041: Affordable Prescriptions for Patients Act. S.1096: Preserve Access to Affordable Generics and Biosimilars Act. H.R.6485/S.43: Skinny Labels, Big Savings Act. PTO rulemaking on inter partes review. H.R.5811: Restoring Americas Leadership in Innovation Act of 2025 (RALIA Act). Settled expectations discretionary denials.

Client expense: $770,000 · Firm income: Not reported

Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

I've lobbied in opposition to creating a presumption of irreparable harm in patent litigation under the RESTORE Patent Rights Act of 2025 (S.708, H.R.1574), against weakening the Patent Trial and Appeal Board through administrative or legislative action (e.g., the PREVAIL Act, H.R.4370, S.2220, S.1553), and against the expansion of patent eligibility in the Patent Eligibility Restoration Act (S.2140, H.R.9474, S.1546). I have also supported disclosure of third-party litigation funding (e.g., H.R.1109 and S.3826). I have also supported limitations on foreign entities that represent a national security risk obtaining and enforcing U.S. patents (e.g., H.R.9142, the Prohibiting Adversarial Patents Act).

Client expense: Not reported · Firm income: $110,000

Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, White House Office

S. 708/H.R. 1574, Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive Patent Rights (RESTORE) Act of 2025; S. 1546/H.R. 3152, Patent Eligibility Restoration Act of 2025; S. 1553/H.R. 3160, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act; Issues related to the International Trade Commission (ITC); Issues related to Intellectual Property Right and Patents.

Client expense: $570,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Software copyright and related policy issues. Software patents and related policy issues. S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S. 1546, Patent Eligibility Restoration Act.

Client expense: Not reported · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, U.S. Copyright Office

Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025

Client expense: $1,180,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1367/H.R.2794, NO FAKES Act of 2025, NO FAKES Act of 2026 / S.4591 Proposals for blocking foreign piracy websites S. 1546/H.R. 3152, Patent Eligibility Restoration Act of 2025 S. 1553/H.R. 3160, Promoting and Respecting Economically Vital American Innovation Leadership Act S. 708/H.R. 1574, RESTORE Patent Rights Act of 2025 H.R. 7140, Customer Legal Ease and Relief (CLEAR) Act

Client expense: $1,396,909 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General patent policy, including issues related to the Patent Trial and Appeal Board, S. 1553/H.R. 3160 the PREVAIL Act, and S. 708/H.R. 1574 the RESTORE Patent Rights Act Issues related to standard essential patents Issues related to licensing obligations, including the Fair Access to Critical Computing Technologies Act (FACCTA) of 2026 Issues related to anti-counterfeit policy General intellectual property, trademark and copyright policy Issues related to patent proceedings and the International Trade Commission, including the Advancing Americas Interests Act General overview of music licensing legal framework

Client expense: $2,740,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Antitrust Legislation ---Oversight Pharmacy Benefit Managers Artificial Intelligence (AI) Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights Compulsory Licensing ---28 U.S.C. 1498 - Patent and copyright cases Data Privacy ---H.R.8413: SECURE Data Act ---Implementation of BIOSECURE Act Drug Patenting ---H.R.3160/S.1553: PREVAIL Act ---H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act ---H.R.9142: Prohibiting Adversarial Patents Act of 2026 ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.527: Prescription Pricing for the People Act ---S.1041: Affordable Prescriptions for Patients Act ---S.1095: Stop STALLING Act ---S.1096: Preserve Access to Affordable Generics and Biosimilars Act ---S.1097: Interagency Patent Coordination and Improvement Act of 2025 ---S.1546/H.R.3152: Patent Eligibility Restoration Act (PERA) ---S.2658: Medication Affordability and Patient Integrity Act ---S.3014: Ensuring Timely Access to Generics Act of 2025 ---Department of Commerce Patent Valuation Fee Proposal ---Patent Litigation Reform ---Patent Tax/fees ---PTAB Reform ---Restrictions on Intellectual Property Rights ---Section 101 Modernization Foreign Drug Data Protection Law ---Implementation of BIOSECURE Act Intellectual Property Enforcement ---China

Client expense: $2,360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, Treasury, Dept of

Patent Protection and IP issues generally. S. 1546, Patent Eligibility and Restoration Act (PERA) HR 3152, Patent Eligibility and Restoration Act (PERA) S. 1553, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) HR 3160, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL)

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE

Discussions regarding automotive right to repair efforts (H.R.1566 - Right to Equitable and Professional Auto Industry Repair Act; entire bill) Discussions regarding several patent bills, including: Patent Eligibility Restoration Act (PERA; S.1546 and H.R. 3152) and Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL; S. 1553; HR 3160) (entire bills) Discussions regarding right to repair efforts in HR 8800 (Sec 861) and S 4784 (Sec 804), the National Defense Authorization Act for FY 2027

Client expense: $1,142,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. H.R.3152/S.1546: Patent Eligibility Restoration Act of 2025. H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act. S.2658: Medication Affordability and Patent Integrity Act. S.1041: Affordable Prescriptions for Patients Act. S.1096: Preserve Access to Affordable Generics and Biosimilars Act. H.R.6485/S.43: Skinny Labels, Big Savings Act. PTO rulemaking on inter partes review. H.R.5811: Restoring Americas Leadership in Innovation Act of 2025 (RALIA Act). Settled expectations discretionary denials.

Client expense: $870,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Patent legislation generally; Intellectual property/antitrust issues; RESTORE Patent Rights Act of 2025 (H.R. 1574, S. 708); PREVAIL Act (S. 1553, H.R. 3160); Patent Eligibility Restoration Act (S. 1546, H.R. 3152); Leadership in CET Act (S. 1833, H.R. 3539). *MATTHEW SHAPANKA DID NOT LOBBY THE SENATE UNTIL AFTER 3/09/24.

Client expense: Not reported · Firm income: $450,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE

Monitor and engage on legislative and administrative action related to intellectual property protection. Monitor and engage on legislative and administrative action related to 35 USC 101 reform. H.R. 1574, RESTORE Patent Rights Act of 2025. H.R. 3152, Patent Eligibility Restoration Act of 2025. H.R. 3160, PREVAIL Act. H.R. 3269, ETHIC Act. S. 708, RESTORE Patent Rights Act of 2025. S. 1546, Patent Eligibility Restoration Act of 2025. S. 1553, PREVAIL Act. S. 2276, ETHIC Act.

Client expense: $1,820,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to intellectual property rights including, but not limited to, patent protection and enforcement, copyright protection and enforcement in international markets, and including S. 1553 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Copyright Office

Issues related to intellectual property, including the NO FAKES Act (S. 1367), counterfeits, music licensing, and issues related to patent reform, International Trade Commission patent investigations, intermediary liability, and patent reform, including the RESTORE Patents Act (H.R. 1574 / S. 708), the Patent Eligibility Restoration (PERA) Act (H.R. 3152 / S. 1546), and the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R. 3160 / S. 1553).

Client expense: $4,360,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Economic Council (NEC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)

Met with Senators, Representatives, and legislative staff to discuss university intellectual property and technology transfer operations, and to encourage support for the PREVAIL (HR 3160, S.1553), PERA (HR 3512, S.1546), and RESTORE (HR 1578, S.704) Acts. Met with Senators, Representatives, and legislative staff to encourage support for efforts to prevent agencies from indiscriminately exercising march-in rights to invalidate university patents or licenses, or to discourage the administration from claiming a portion of patent royalties.

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Federal Trade Commission related issues Issues related to the Patent Act, no specific bill Issues related to March-In/Bayh Dole, WTO/TRIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 (RESTORE) S.1553/HR3160-- Promoting and Respecting Economically Viable American Innovation Act (PREVAIL) S. 1546/ HR 3152-- Patent Eligibility Restoration Act of 2025 (PERA) S 2276 / HR 3269 Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 43/HR 6485 Skinny Labels Big Savings Act S.2658 Medication Affordability and Patent Integrity Act S. 3452/HR 6624 Biological Intellectual Property Protection Act of 2025

Client expense: $2,440,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 43: Skinny Labels, Big Savings Act S. 1040: Drug Competition Enhancement Act S. 1041: Affordable Prescriptions for Patients Act S. 1095: Stop STALLING Act S. 1096: Preserve Access to Affordable Generics and Biosimilars Act S. 1097: Interagency Patent Coordination and Improvement Act of 2025 S. 1546: Patent Eligibility Restoration Act of 2025 (PERA) S. 1553: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) S. 2276: Eliminating Thickets to Increase Competition Act (ETHIC Act) S. 2620: REMEDY Act S. 2658: Medication Affordability and Patent Integrity Act S. 3452: Biological Intellectual Protection Act of 2025 H.R. 890: Stopping Pharmas Ripoffs and Drug Savings For All Act H.R. 3152: Patent Eligibility Restoration Act of 2025 (PERA) H.R. 3160: Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) H.R. 3269: Eliminating Thickets to Increase Competition Act (ETHIC Act) H.R. 4570: Interagency Patent Coordination and Improvement Act of 2025 H.R. 6485: Skinny Labels, Big Savings Act H.R. 6624: Biological Intellectual Property Protection Act of 2025 Biopharmaceutical innovation policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues AI patent policy issues Patent eligibility policy issues Post-grant proceeding policy issues Patent submission policy issues Patent fee policy issues

Client expense: $7,360,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE